Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration

Details for Australian Patent Application No. 2010258751 (hide)

Owner Elevation Pharmaceuticals, Inc.

Inventors Gerhart, William; Tutuncu, Ahmet

Agent Shelston IP

Pub. Number AU-A-2010258751

PCT Pub. Number WO2010/144628

Priority 61/185,524 09.06.09 US; 61/185,528 09.06.09 US

Filing date 9 June 2010

Wipo publication date 16 December 2010

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/19 (2006.01)

A61K 31/195 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/144628 Priority application(s): WO2010/144628

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258752-Hemoglobin compositions

2010258731-Generating test data